Panel formed by Centre to review pricing framework for drugs & medical devices will have representatives from Indian Pharmaceutical Alliance & Indian Drug Manufacturers Association.
Drugmakers have also requested the government to consider ‘essentiality’ of the drug, and not its ‘turnover’, as the criterion for inclusion under NLEM.
India has one of the lowest drug prices in the world, yet many Indians are deprived of life-saving drugs. Price controls haven't been enough to bridge this gap.
China patiently invested capital, skill and technology in coal gasification. Unlike it, we won’t move from words to action. As crude prices decline, we lose interest.
COMMENTS